Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366
10 juin 2024 08h00 HE
|
Assembly Biosciences, Inc.
– Phase 1a study portion of single ascending dosing in healthy participants will inform the development of ABI-5366 with interim data expected in Q3 2024 – – Phase 1b study portion of multiple...
Flexible Plastic Packaging Market to accrue USD 250 Billion by 2032, Says Global Market Insights inc.
10 juin 2024 04h30 HE
|
Global Market Insights Inc.
Selbyville, Delaware, June 10, 2024 (GLOBE NEWSWIRE) -- Flexible Plastic Packaging Market is anticipated to record USD 250 billion by the end of 2032, as per a recent study by Global Market Insights...
$14 Billion Virtual Reality (VR) Neuropsychological Therapy Market (2024-2034) by Technology, Offering, End-user and Region Featuring Profiles of Oculus VR (Facebook Technologies), MindMaze, Psious, and More
07 juin 2024 04h19 HE
|
Research and Markets
Dublin, June 07, 2024 (GLOBE NEWSWIRE) -- The "Global Virtual Reality Neuropsychological Therapy Market" report has been added to ResearchAndMarkets.com's offering.The global virtual reality...
BioNTX Announces 10th Annual iC³® Life Science & Healthcare Innovation Summit
06 juin 2024 10h00 HE
|
Bio North Texas
BioNTX, the leading biotechnology trade organization in North Texas, is thrilled to announce the 10th Annual iC³® Life Science Summit.
Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024
05 juin 2024 08h00 HE
|
Assembly Biosciences, Inc.
-- Poster highlights promising preclinical profile of ABI-6250 ahead of entry into the clinic, expected by end of 2024 -- SOUTH SAN FRANCISCO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Assembly...
CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting
05 juin 2024 07h00 HE
|
CytoSorbents
CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting
Lumos Pharma Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024
04 juin 2024 09h00 HE
|
Lumos Pharma, Inc.
AUSTIN, Texas, June 04, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced today details of...
CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract
04 juin 2024 07h00 HE
|
CytoSorbents
CTSO STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024
Lynch Carpenter Investigates Claims in Sav-RX Data Breach
31 mai 2024 17h21 HE
|
Lynch Carpenter
PITTSBURGH, May 31, 2024 (GLOBE NEWSWIRE) -- Sav-Rx recently announced that it suffered from a cybersecurity attack in October of 2023, which impacted the personal information of approximately 2.8...
Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034: Rising Opportunities for IBD Drugs in Asian Markets
31 mai 2024 06h32 HE
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the Inflammatory...